November 6, 2026. The European Commission has cleared Amplifon’s acquisition of GN Store Nord’s hearing aid business. The big deal for the hearing care market was announced in March, 2026. This November 6 announcement removes the final regulatory obstacle....
Continue reading at Audiology Worldnews
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate acquisition announcement with no immediate implications for clinical practice.
The merger significantly consolidates the European hearing healthcare market, potentially reshaping supply relationships, brand availability, and competitive pricing for clinics and consumers alike.
- 01European Commission approved Amplifon's acquisition of GN Store Nord's hearing aid division on November 6, 2026.
- 02The deal was originally announced in March 2026 and EC approval was the final regulatory hurdle.
- 03Amplifon is already one of the largest global hearing clinic networks; adding GN's hearing aid business increases vertical integration.
- 04The acquisition could affect brand availability and pricing dynamics for independent hearing aid dispensers in Europe.
- 05No clinical or product changes have been announced as a direct result of the approval.
The European Commission approved Amplifon's acquisition of GN Store Nord's hearing aid business on November 6, 2026.
press releasesupportedThe EC approval was the final regulatory hurdle for the deal announced in March 2026.
press releasesupported
